Literature DB >> 10792030

Collaboration of signal transducer and activator of transcription 1 (STAT1) and BRCA1 in differential regulation of IFN-gamma target genes.

T Ouchi1, S W Lee, M Ouchi, S A Aaronson, C M Horvath.   

Abstract

Most of the activities of IFN-gamma are the result of STAT1-mediated transcriptional responses. In this study, we show that the BRCA1 tumor suppressor acts in concert with STAT1 to differentially activate transcription of a subset of IFN-gamma target genes and mediates growth inhibition by this cytokine. After IFN-gamma treatment, induction of the cyclin-dependent kinase inhibitor, p21WAF1, was synergistically activated by BRCA1, whereas the IRF-1 gene was unaffected. Importantly, the differential induction of p21WAF1 was impaired in breast cancer cells homozygous for the mutant BRCA1 5382C allele. Biochemical analysis illustrated that the mechanism of this transcriptional synergy involves interaction between BRCA1 aa 502-802 and the C-terminal transcriptional activation domain of STAT1 including Ser-727 whose phosphorylation is crucial for transcriptional activation. Significantly, STAT1 proteins mutated at Ser-727 bind poorly to BRCA1, reinforcing the importance of Ser-727 in the recruitment of transcriptional coactivators by STAT proteins. These findings reveal a novel mechanism for BRCA1 function in the IFN-gamma-dependent tumor surveillance system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10792030      PMCID: PMC25807          DOI: 10.1073/pnas.080469697

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  CBP/p300 interact with and function as transcriptional coactivators of BRCA1.

Authors:  G M Pao; R Janknecht; H Ruffner; T Hunter; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  Proteins of transcription factor ISGF-3: one gene encodes the 91-and 84-kDa ISGF-3 proteins that are activated by interferon alpha.

Authors:  C Schindler; X Y Fu; T Improta; R Aebersold; J E Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

3.  Interferon inhibits the establishment of competence in Go/S-phase transition.

Authors:  S L Lin; T Kikuchi; W J Pledger; I Tamm
Journal:  Science       Date:  1986-07-18       Impact factor: 47.728

4.  Interferon affects both G1 and S+G2 in cells stimulated from quiescence to growth.

Authors:  F Balkwill; J Taylor-Papadimitriou
Journal:  Nature       Date:  1978-08-24       Impact factor: 49.962

5.  Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes.

Authors:  H Harada; T Fujita; M Miyamoto; Y Kimura; M Maruyama; A Furia; T Miyata; T Taniguchi
Journal:  Cell       Date:  1989-08-25       Impact factor: 41.582

6.  Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway.

Authors:  S Pellegrini; J John; M Shearer; I M Kerr; G R Stark
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

7.  DNA topology and a minimal set of basal factors for transcription by RNA polymerase II.

Authors:  J D Parvin; P A Sharp
Journal:  Cell       Date:  1993-05-07       Impact factor: 41.582

8.  A phase I trial of retroviral BRCA1sv gene therapy in ovarian cancer.

Authors:  D L Tait; P S Obermiller; S Redlin-Frazier; R A Jensen; P Welcsh; J Dann; M C King; D H Johnson; J T Holt
Journal:  Clin Cancer Res       Date:  1997-11       Impact factor: 12.531

9.  High-frequency mutagenesis of human cells and characterization of a mutant unresponsive to both alpha and gamma interferons.

Authors:  R McKendry; J John; D Flavell; M Müller; I M Kerr; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

10.  p53-catalyzed annealing of complementary single-stranded nucleic acids.

Authors:  P Oberosler; P Hloch; U Ramsperger; H Stahl
Journal:  EMBO J       Date:  1993-06       Impact factor: 11.598

View more
  53 in total

1.  BRCA1 can stimulate gene transcription by a unique mechanism.

Authors:  G Nadeau; N Boufaied; A Moisan; K M Lemieux; C Cayanan; A N Monteiro; L Gaudreau
Journal:  EMBO Rep       Date:  2000-09       Impact factor: 8.807

Review 2.  Stat proteins and oncogenesis.

Authors:  Jacqueline Bromberg
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

3.  The Epstein-Barr virus SM protein induces STAT1 and interferon-stimulated gene expression.

Authors:  Vivian Ruvolo; Lorena Navarro; Clare E Sample; Michael David; Seung Sung; Sankar Swaminathan
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

4.  Impaired DNA damage response in cells expressing an exon 11-deleted murine Brca1 variant that localizes to nuclear foci.

Authors:  L J Huber; T W Yang; C J Sarkisian; S R Master; C X Deng; L A Chodosh
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

5.  The antagonistic effect between STAT1 and Survivin and its clinical significance in gastric cancer.

Authors:  Hao Deng; Hongyan Zhen; Zhengqi Fu; Xuan Huang; Hongyan Zhou; Lijiang Liu
Journal:  Oncol Lett       Date:  2011-09-16       Impact factor: 2.967

6.  Regulation of ATM/DNA-PKcs Phosphorylation by BRCA1-Associated BAAT1.

Authors:  Mutsuko Ouchi; Toru Ouchi
Journal:  Genes Cancer       Date:  2010-12

7.  BRCA1 and BRCA2 mutations and treatment strategies for breast cancer.

Authors:  Inês Godet; Daniele M Gilkes
Journal:  Integr Cancer Sci Ther       Date:  2017-02-27

8.  The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells.

Authors:  Yongxian Ma; Pragati Katiyar; Laundette P Jones; Saijun Fan; Yiyu Zhang; Priscilla A Furth; Eliot M Rosen
Journal:  Mol Endocrinol       Date:  2005-08-18

9.  Methylation of the tumor suppressor protein, BRCA1, influences its transcriptional cofactor function.

Authors:  Irene Guendel; Lawrence Carpio; Caitlin Pedati; Arnold Schwartz; Christine Teal; Fatah Kashanchi; Kylene Kehn-Hall
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

10.  BRCA1 tumours correlate with a HIF-1alpha phenotype and have a poor prognosis through modulation of hydroxylase enzyme profile expression.

Authors:  M Yan; M Rayoo; E A Takano; H Thorne; S B Fox
Journal:  Br J Cancer       Date:  2009-09-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.